FULL TEST Xi
Xi
TEST BANK FOR PHARMACOTHERAPEUTICS FOR ADVANCE
Xi Xi
Xi
Xi Xi
D PRACTICE A PRACTICAL APPROACH 5TH
Xi Xi Xi Xi Xi
EDITION BY VIRGINIA POOLE ARCANGELO; ANDREW
Xi Xi Xi Xi Xi Xi
PETERSON; VERONICA WILBUR; JENNIFER A. REINHOLD
Xi Xi Xi Xi Xi
PRINTED PDF I ORIGINAL DIRECTLY FROM THE PUBLISHER I 1OO%
Xi Xi Xi Xi Xi Xi Xi Xi Xi
VERIFIED ANSWERS ] DOWNLOAD IMMEDIATELY AFTER THE ORDER
Xi Xi Xi Xi Xi Xi Xi
['LIZ)LI12%5IL!
[LI.GIL
Complete Test bank, All Chapters are included.
Xi X i Xi X i Xi X i
For more Test banks, ATI, HES! exams, and more contact us.
Xi Xi Xi Xi Xi Xi Xi Xi Xi Xi
, Table of content Xi Xi
Chapter I Issues for the Practitioner in Drug Therapy
Xi Xi Xi Xi Xi Xi Xi Xi
Chapter 2 Pharmacokinetic Basis of Therapeutics and Pharmacodynamic Principles
Xi Xi Xi Xi Xi Xi Xi Xi
Chapter 3 Impact of Drug Interactions and Adverse Events on Therapeutics C
Xi Xi X i Xi Xi Xi X i Xi Xi X i Xi Xi
hapter 4 Principles of Pharmacotherapy in Pediatrics, Pregnancy, and Lactation C
Xi Xi Xi Xi Xi Xi Xi Xi Xi Xi
hapter 5 Pharmacotherapy Principles in Older Adults
Xi Xi Xi Xi Xi Xi
Chapter 6 Principles of Antimicrobial Therapy Chapt
Xi Xi Xi Xi Xi Xi
er 7 Pharmacogenomies
Xi Xi
Chapter 8 The Economics of Pharmacotherapeutics
Xi Xi Xi Xi Xi Xi
Chapter 9 Pharmacotherapy of Pain Management
Xi Xi Xi Xi Xi
Chapter I0 Pain Management in Opioid Use Disorder (OUD) Patients
Xi Xi Xi Xi Xi Xi Xi Xi Xi Xi
Chapter 11 Cannabis and Pain Management
Xi Xi Xi Xi Xi
Chapter 12 Contact Dermatitis Xi Xi Xi
Chapter 13 Fungal, Viral, and Bacterial Infections of the Skin
Xi Xi Xi Xi Xi Xi Xi Xi Xi Xi
Chapter 14 Psoriasis Xi Xi
Chapter I5 Acne Vulgaris and Rosacea Chapt
Xi Xi Xi Xi Xi Xi
er 16 Ophthalmic Disorders
Xi Xi Xi
Chapter I7 Otitis Media and Otitis Externa C
Xi Xi Xi Xi Xi Xi Xi
hapter I8 Hypertension Xi Xi
Chapter I9 Hyperlipidemia Xi Xi
Chapter 20 Chronic Stable Angina and Myocardial Infarction
Xi Xi Xi Xi Xi Xi Xi Xi
Chapter 2I Heart Failure Xi Xi Xi
Chapter 22 Arrhythmias Xi Xi
Chapter 23 Respiratory Infections
Xi Xi Xi
Chapter 24 Asthma and Chronic Obstructive Pulmonary Disease Cha
Xi Xi Xi Xi Xi Xi Xi Xi
pter 25 Gastric, Functional, and Inflammatory Bowel Disorders Chapt
Xi Xi Xi Xi Xi Xi Xi Xi
er 26 Gastroesophageal Reflux Disease and Peptic Ulcer Disease Chap
Xi Xi Xi Xi Xi Xi Xi Xi Xi
ter 27 Liver Diseases
Xi Xi Xi
Chapter 28 Urinary Tract Infection
Xi Xi Xi Xi
Chapter 29 Prostatic Disorders and Erectile Dysfunction Chap
Xi Xi Xi Xi Xi Xi Xi
ter 30 Overactive Bladder
Xi Xi Xi
Chapter 3I Sexually Transmitted Infection
Xi Xi Xi Xi
s Chapter 32 Osteoarthritis and Gout Cha
Xi Xi Xi Xi Xi Xi
pter 33 Osteoporosis
Xi Xi
Chapter 34 Rheumatoid Arthritis Xi Xi Xi Xi
Chapter 35 Headaches Xi Xi
Chapter 36 Seizure Disorders Xi Xi Xi Xi
Chapter 37 Alzheimer's Disease Xi Xi Xi X i
Chapter 38 Parkinson's Diseas Xi Xi Xi
e
Chapter 39 Major Depressive Disorder and Bipolar Disorders
Xi Xi Xi Xi Xi Xi Xi Xi
Chapter 40 Anxiety Disorders Xi Xi Xi
Chapter 41 Sleep Disorders Xi X i X i
Chapter 42 Attention Deficit Hyperactivity Disorder
Xi Xi Xi Xi Xi Xi
Chapter 43 Substance Use Disorders
Xi Xi Xi Xi
Chapter 44 Diabetes Mellitus Xi Xi Xi
Chapter 45 Thyroid and Parathyroid Disorders
Xi Xi Xi Xi Xi
,Chapter 46 Allergies and Allergic Reactions
Xi Xi Xi Xi Xi
Chapter 47 Human Immunodeficiency Viru
Xi Xi Xi Xi Xi
s Chapter 48 Organ Transplantation
Xi Xi Xi Xi
Chapter 49 Thromboembolic Disorders Ch
Xi Xi Xi Xi
apter 50 Anemias
Xi Xi
Chapter 5l Immunizations Cha
Xi Xi Xi
pter 52 Smoking Cessation Cha
Xi Xi Xi Xi
pter 53 Weight Loss Chapter 5
Xi Xi Xi Xi Xi
4 Contraception
Xi
Chapter 55 Menopause Xi Xi
Chapter 56 Vaginitis Xi Xi
, Xi
X i Xi
lOMoAR cPSD| 21007614
Chapter 1 Issues for the Practitioner in Drug Therapy
Xi Xi Xi Xi Xi Xi Xi Xi
MULTIPLE CHOICE Xi
1. Nurse practitioner prescriptive authority is regulated by:
Xi Xi Xi Xi Xi Xi
A. The National Council of State Boards of Nursing
Xi Xi Xi Xi Xi Xi Xi
B. The U.S. Drug Enforcement Administration
Xi Xi Xi Xi
C. The State Board of Nursing for each state
Xi Xi Xi Xi Xi Xi Xi
D. The State Board of Pharmacy
Xi Xi Xi Xi
ANS: C X i PTS: X i 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
Xi Xi Xi Xi Xi Xi Xi
A. The National Council of State Boards of Nursing
Xi Xi Xi Xi Xi Xi Xi
B. The U.S. Drug Enforcement Administration
Xi Xi Xi Xi
C. The State Board of Nursing
Xi Xi Xi Xi
D. The State Board of Medical Examiners
Xi Xi Xi Xi Xi
ANS: D X i PTS: X i 1
3. Clinical judgment in prescribing includes:
Xi Xi Xi Xi
A. Factoring in the cost to the patient of the medication prescribed
Xi Xi Xi Xi Xi Xi Xi Xi Xi Xi
B. Always prescribing the newest medication available for the disease process
Xi Xi Xi Xi Xi Xi Xi Xi Xi
C. Handing out drug samples to poor patients
Xi Xi Xi Xi Xi Xi
D. Prescribing all generic medications to cut costs
Xi Xi Xi Xi Xi Xi
ANS: A X i PTS: X i 1
4. Criteria for choosing an effective drug for a disorder include:
Xi Xi Xi Xi Xi Xi Xi Xi Xi
A. Asking the patient what drug they think would work best for them
Xi Xi Xi Xi Xi Xi Xi Xi Xi Xi Xi
B. Consulting nationally recognized guidelines for disease management
Xi Xi Xi Xi Xi Xi
C. Prescribing medications that are available as samples before writing a prescription
Xi Xi Xi Xi Xi Xi Xi Xi Xi Xi
D. Following U.S. Drug Enforcement Administration (DEA) guidelines fo
Xi Xi Xi Xi Xi Xi Xi
r prescribing
Xi
ANS: B X i PTS: X i 1
5. Nurse practitioner practice may thrive under health-care reform due to:
Xi Xi Xi Xi Xi Xi Xi Xi Xi
A. The demonstrated ability of nurse practitioners to control costs and improve patie
Xi Xi Xi Xi Xi Xi Xi Xi Xi Xi Xi
nt outcomesXi
B. The fact that nurse practitioners will be able to practice independently
Xi Xi Xi Xi Xi Xi Xi Xi Xi Xi
C. The fact that nurse practitioners will have full reimbursement under health-
Xi Xi Xi Xi Xi Xi Xi Xi Xi Xi
care reform Xi
D. The ability to shift accountability for Medicaid to the state level
Xi Xi Xi Xi Xi Xi Xi Xi Xi Xi
ANS: A X i PTS: X i 1
Xi
TEST BANK FOR PHARMACOTHERAPEUTICS FOR ADVANCE
Xi Xi
Xi
Xi Xi
D PRACTICE A PRACTICAL APPROACH 5TH
Xi Xi Xi Xi Xi
EDITION BY VIRGINIA POOLE ARCANGELO; ANDREW
Xi Xi Xi Xi Xi Xi
PETERSON; VERONICA WILBUR; JENNIFER A. REINHOLD
Xi Xi Xi Xi Xi
PRINTED PDF I ORIGINAL DIRECTLY FROM THE PUBLISHER I 1OO%
Xi Xi Xi Xi Xi Xi Xi Xi Xi
VERIFIED ANSWERS ] DOWNLOAD IMMEDIATELY AFTER THE ORDER
Xi Xi Xi Xi Xi Xi Xi
['LIZ)LI12%5IL!
[LI.GIL
Complete Test bank, All Chapters are included.
Xi X i Xi X i Xi X i
For more Test banks, ATI, HES! exams, and more contact us.
Xi Xi Xi Xi Xi Xi Xi Xi Xi Xi
, Table of content Xi Xi
Chapter I Issues for the Practitioner in Drug Therapy
Xi Xi Xi Xi Xi Xi Xi Xi
Chapter 2 Pharmacokinetic Basis of Therapeutics and Pharmacodynamic Principles
Xi Xi Xi Xi Xi Xi Xi Xi
Chapter 3 Impact of Drug Interactions and Adverse Events on Therapeutics C
Xi Xi X i Xi Xi Xi X i Xi Xi X i Xi Xi
hapter 4 Principles of Pharmacotherapy in Pediatrics, Pregnancy, and Lactation C
Xi Xi Xi Xi Xi Xi Xi Xi Xi Xi
hapter 5 Pharmacotherapy Principles in Older Adults
Xi Xi Xi Xi Xi Xi
Chapter 6 Principles of Antimicrobial Therapy Chapt
Xi Xi Xi Xi Xi Xi
er 7 Pharmacogenomies
Xi Xi
Chapter 8 The Economics of Pharmacotherapeutics
Xi Xi Xi Xi Xi Xi
Chapter 9 Pharmacotherapy of Pain Management
Xi Xi Xi Xi Xi
Chapter I0 Pain Management in Opioid Use Disorder (OUD) Patients
Xi Xi Xi Xi Xi Xi Xi Xi Xi Xi
Chapter 11 Cannabis and Pain Management
Xi Xi Xi Xi Xi
Chapter 12 Contact Dermatitis Xi Xi Xi
Chapter 13 Fungal, Viral, and Bacterial Infections of the Skin
Xi Xi Xi Xi Xi Xi Xi Xi Xi Xi
Chapter 14 Psoriasis Xi Xi
Chapter I5 Acne Vulgaris and Rosacea Chapt
Xi Xi Xi Xi Xi Xi
er 16 Ophthalmic Disorders
Xi Xi Xi
Chapter I7 Otitis Media and Otitis Externa C
Xi Xi Xi Xi Xi Xi Xi
hapter I8 Hypertension Xi Xi
Chapter I9 Hyperlipidemia Xi Xi
Chapter 20 Chronic Stable Angina and Myocardial Infarction
Xi Xi Xi Xi Xi Xi Xi Xi
Chapter 2I Heart Failure Xi Xi Xi
Chapter 22 Arrhythmias Xi Xi
Chapter 23 Respiratory Infections
Xi Xi Xi
Chapter 24 Asthma and Chronic Obstructive Pulmonary Disease Cha
Xi Xi Xi Xi Xi Xi Xi Xi
pter 25 Gastric, Functional, and Inflammatory Bowel Disorders Chapt
Xi Xi Xi Xi Xi Xi Xi Xi
er 26 Gastroesophageal Reflux Disease and Peptic Ulcer Disease Chap
Xi Xi Xi Xi Xi Xi Xi Xi Xi
ter 27 Liver Diseases
Xi Xi Xi
Chapter 28 Urinary Tract Infection
Xi Xi Xi Xi
Chapter 29 Prostatic Disorders and Erectile Dysfunction Chap
Xi Xi Xi Xi Xi Xi Xi
ter 30 Overactive Bladder
Xi Xi Xi
Chapter 3I Sexually Transmitted Infection
Xi Xi Xi Xi
s Chapter 32 Osteoarthritis and Gout Cha
Xi Xi Xi Xi Xi Xi
pter 33 Osteoporosis
Xi Xi
Chapter 34 Rheumatoid Arthritis Xi Xi Xi Xi
Chapter 35 Headaches Xi Xi
Chapter 36 Seizure Disorders Xi Xi Xi Xi
Chapter 37 Alzheimer's Disease Xi Xi Xi X i
Chapter 38 Parkinson's Diseas Xi Xi Xi
e
Chapter 39 Major Depressive Disorder and Bipolar Disorders
Xi Xi Xi Xi Xi Xi Xi Xi
Chapter 40 Anxiety Disorders Xi Xi Xi
Chapter 41 Sleep Disorders Xi X i X i
Chapter 42 Attention Deficit Hyperactivity Disorder
Xi Xi Xi Xi Xi Xi
Chapter 43 Substance Use Disorders
Xi Xi Xi Xi
Chapter 44 Diabetes Mellitus Xi Xi Xi
Chapter 45 Thyroid and Parathyroid Disorders
Xi Xi Xi Xi Xi
,Chapter 46 Allergies and Allergic Reactions
Xi Xi Xi Xi Xi
Chapter 47 Human Immunodeficiency Viru
Xi Xi Xi Xi Xi
s Chapter 48 Organ Transplantation
Xi Xi Xi Xi
Chapter 49 Thromboembolic Disorders Ch
Xi Xi Xi Xi
apter 50 Anemias
Xi Xi
Chapter 5l Immunizations Cha
Xi Xi Xi
pter 52 Smoking Cessation Cha
Xi Xi Xi Xi
pter 53 Weight Loss Chapter 5
Xi Xi Xi Xi Xi
4 Contraception
Xi
Chapter 55 Menopause Xi Xi
Chapter 56 Vaginitis Xi Xi
, Xi
X i Xi
lOMoAR cPSD| 21007614
Chapter 1 Issues for the Practitioner in Drug Therapy
Xi Xi Xi Xi Xi Xi Xi Xi
MULTIPLE CHOICE Xi
1. Nurse practitioner prescriptive authority is regulated by:
Xi Xi Xi Xi Xi Xi
A. The National Council of State Boards of Nursing
Xi Xi Xi Xi Xi Xi Xi
B. The U.S. Drug Enforcement Administration
Xi Xi Xi Xi
C. The State Board of Nursing for each state
Xi Xi Xi Xi Xi Xi Xi
D. The State Board of Pharmacy
Xi Xi Xi Xi
ANS: C X i PTS: X i 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
Xi Xi Xi Xi Xi Xi Xi
A. The National Council of State Boards of Nursing
Xi Xi Xi Xi Xi Xi Xi
B. The U.S. Drug Enforcement Administration
Xi Xi Xi Xi
C. The State Board of Nursing
Xi Xi Xi Xi
D. The State Board of Medical Examiners
Xi Xi Xi Xi Xi
ANS: D X i PTS: X i 1
3. Clinical judgment in prescribing includes:
Xi Xi Xi Xi
A. Factoring in the cost to the patient of the medication prescribed
Xi Xi Xi Xi Xi Xi Xi Xi Xi Xi
B. Always prescribing the newest medication available for the disease process
Xi Xi Xi Xi Xi Xi Xi Xi Xi
C. Handing out drug samples to poor patients
Xi Xi Xi Xi Xi Xi
D. Prescribing all generic medications to cut costs
Xi Xi Xi Xi Xi Xi
ANS: A X i PTS: X i 1
4. Criteria for choosing an effective drug for a disorder include:
Xi Xi Xi Xi Xi Xi Xi Xi Xi
A. Asking the patient what drug they think would work best for them
Xi Xi Xi Xi Xi Xi Xi Xi Xi Xi Xi
B. Consulting nationally recognized guidelines for disease management
Xi Xi Xi Xi Xi Xi
C. Prescribing medications that are available as samples before writing a prescription
Xi Xi Xi Xi Xi Xi Xi Xi Xi Xi
D. Following U.S. Drug Enforcement Administration (DEA) guidelines fo
Xi Xi Xi Xi Xi Xi Xi
r prescribing
Xi
ANS: B X i PTS: X i 1
5. Nurse practitioner practice may thrive under health-care reform due to:
Xi Xi Xi Xi Xi Xi Xi Xi Xi
A. The demonstrated ability of nurse practitioners to control costs and improve patie
Xi Xi Xi Xi Xi Xi Xi Xi Xi Xi Xi
nt outcomesXi
B. The fact that nurse practitioners will be able to practice independently
Xi Xi Xi Xi Xi Xi Xi Xi Xi Xi
C. The fact that nurse practitioners will have full reimbursement under health-
Xi Xi Xi Xi Xi Xi Xi Xi Xi Xi
care reform Xi
D. The ability to shift accountability for Medicaid to the state level
Xi Xi Xi Xi Xi Xi Xi Xi Xi Xi
ANS: A X i PTS: X i 1